Jazz Pharmaceuticals on Feb. 3 announced the acquisition of GW Pharmaceuticals for a total consideration of $7.
Shares in GW Pharmaceuticals (GWPH) surged 21% in Tuesday’s trading, after the cannabis biopharma reported beats all round on the back of strong Epidiolex …
Cannabis stock GW Pharma (GWPH) has announced that the US Food and Drug Administration (FDA) has approved Epidiolex oral solution for the treatment …
Cannabis stock GW Pharma (GWPH) has announced that the UK Home Office has lowered its classification of Epidyolex (cannabidiol). This change will take …
Cannabinoid prescription medicines stock GW Pharmaceuticals (GWPH) has reported particularly strong first quarter earnings results, with US sales of Epidiolex at $116.1M, up …
Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them …
The last decade, since the financial crisis of 2008 and the subsequent Great Recession, have seen a heavy dominance of US companies in …
GW Pharmaceuticals (GWPH) announced on Monday that it had received approval to sell its epilepsy drug in the world’s largest market, as measured …
The good news for GW Pharmaceuticals (GWPH) was it generated a profit in its latest reporting period. The bad news is it was …
June has been one roller coaster ride for cannabis stocks. First, the FDA reported that CBD be treated like a drug causing cannabis …